| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
94,586 |
75,772 |
$5.58M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
9,545 |
8,721 |
$1.58M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
13,001 |
11,941 |
$1.50M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
31,705 |
29,414 |
$1.17M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,657 |
4,227 |
$1.06M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
28,908 |
26,358 |
$722K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,891 |
4,365 |
$456K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
6,772 |
6,349 |
$387K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
6,905 |
4,115 |
$373K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
20,844 |
6,430 |
$372K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,381 |
3,152 |
$353K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,017 |
1,896 |
$300K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,576 |
2,275 |
$259K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
3,281 |
3,150 |
$230K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
7,183 |
6,517 |
$169K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
3,215 |
2,994 |
$162K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
9,827 |
3,458 |
$137K |
| 71046 |
Radiologic examination, chest; 2 views |
3,804 |
3,610 |
$133K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
3,650 |
2,781 |
$131K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,182 |
3,441 |
$130K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
5,255 |
4,634 |
$122K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,822 |
1,644 |
$105K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,008 |
1,980 |
$102K |
| 99215 |
Prolong outpt/office vis |
1,964 |
1,879 |
$85K |
| 80061 |
Lipid panel |
11,790 |
11,510 |
$83K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
811 |
446 |
$79K |
| 97597 |
|
2,422 |
1,213 |
$78K |
| 90837 |
Psychotherapy, 53 minutes with patient |
749 |
486 |
$77K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
5,097 |
4,749 |
$74K |
| 98928 |
|
6,519 |
5,761 |
$73K |
| 76830 |
Ultrasound, transvaginal |
1,006 |
970 |
$70K |
| 80053 |
Comprehensive metabolic panel |
30,076 |
27,410 |
$69K |
| 97162 |
|
2,050 |
1,989 |
$66K |
| 84443 |
Thyroid stimulating hormone (TSH) |
12,331 |
11,825 |
$66K |
| 71045 |
Radiologic examination, chest; single view |
2,157 |
1,945 |
$64K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
996 |
961 |
$60K |
| Q3014 |
Telehealth originating site facility fee |
4,906 |
4,191 |
$57K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,824 |
1,769 |
$56K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
165 |
153 |
$51K |
| 20610 |
|
859 |
742 |
$50K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,858 |
4,621 |
$50K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
3,995 |
3,771 |
$48K |
| 86900 |
|
1,417 |
1,299 |
$47K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
3,879 |
3,661 |
$47K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,979 |
3,869 |
$45K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
578 |
408 |
$45K |
| 11721 |
|
5,569 |
5,402 |
$45K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
29,677 |
26,034 |
$44K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
362 |
342 |
$40K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
1,893 |
1,866 |
$38K |
| 97014 |
|
3,120 |
959 |
$38K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,881 |
2,727 |
$36K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
356 |
334 |
$35K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
556 |
539 |
$34K |
| 90677 |
|
360 |
358 |
$34K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
8,565 |
7,649 |
$31K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
11,069 |
10,758 |
$30K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
516 |
501 |
$30K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
2,401 |
1,078 |
$29K |
| 36415 |
Collection of venous blood by venipuncture |
36,897 |
32,501 |
$27K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
11,515 |
10,298 |
$25K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
531 |
453 |
$23K |
| 90832 |
Psychotherapy, 30 minutes with patient |
614 |
476 |
$23K |
| 98927 |
|
2,259 |
2,043 |
$22K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
189 |
187 |
$21K |
| 76801 |
|
290 |
267 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
704 |
668 |
$21K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
264 |
259 |
$18K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,434 |
2,325 |
$18K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
246 |
238 |
$17K |
| 99205 |
Prolong outpt/office vis |
212 |
206 |
$16K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
195 |
172 |
$15K |
| 99406 |
|
1,609 |
1,434 |
$15K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
147 |
144 |
$14K |
| 97035 |
|
3,324 |
1,124 |
$14K |
| 82728 |
|
2,662 |
2,558 |
$13K |
| 76000 |
|
104 |
95 |
$12K |
| 87088 |
|
7,075 |
6,514 |
$12K |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
28 |
15 |
$12K |
| 90686 |
|
1,331 |
1,267 |
$12K |
| 82607 |
|
2,512 |
2,420 |
$11K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
258 |
242 |
$11K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
222 |
219 |
$11K |
| 0012A |
|
538 |
513 |
$11K |
| 96415 |
|
317 |
201 |
$11K |
| 73630 |
|
1,519 |
1,331 |
$11K |
| 99443 |
|
437 |
400 |
$10K |
| 84702 |
|
1,633 |
1,263 |
$10K |
| 84439 |
|
2,741 |
2,631 |
$10K |
| 0011A |
|
558 |
532 |
$10K |
| 71271 |
|
179 |
176 |
$9K |
| 98929 |
|
531 |
508 |
$9K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
335 |
285 |
$9K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
940 |
427 |
$8K |
| 90658 |
|
960 |
844 |
$8K |
| 93017 |
|
440 |
413 |
$8K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
98 |
92 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
352 |
247 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
115 |
115 |
$8K |
| 96127 |
|
1,133 |
998 |
$8K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
6,028 |
5,067 |
$8K |
| 87081 |
|
3,141 |
2,957 |
$8K |
| 73030 |
|
651 |
576 |
$7K |
| 83735 |
|
7,612 |
6,619 |
$7K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
125 |
125 |
$7K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
26 |
25 |
$7K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
1,344 |
883 |
$7K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
29 |
28 |
$7K |
| 80306 |
|
1,862 |
1,735 |
$6K |
| 73564 |
|
443 |
377 |
$6K |
| 85027 |
|
3,074 |
2,835 |
$6K |
| 83550 |
|
2,199 |
2,106 |
$6K |
| 83540 |
|
2,471 |
2,371 |
$6K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
228 |
195 |
$5K |
| 95251 |
|
459 |
430 |
$5K |
| 86592 |
|
1,561 |
1,485 |
$5K |
| 72100 |
|
278 |
256 |
$5K |
| 87631 |
|
1,881 |
1,805 |
$5K |
| 95250 |
|
110 |
96 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
72 |
72 |
$5K |
| 97161 |
|
140 |
134 |
$5K |
| 87390 |
|
1,159 |
1,070 |
$4K |
| 87077 |
|
3,205 |
2,947 |
$4K |
| 86140 |
|
3,625 |
3,270 |
$4K |
| 86803 |
|
1,730 |
1,654 |
$4K |
| 73130 |
|
615 |
418 |
$4K |
| G0008 |
Administration of influenza virus vaccine |
1,167 |
1,163 |
$4K |
| 64450 |
|
14 |
13 |
$4K |
| 99490 |
Ccm add 20min |
101 |
101 |
$4K |
| 73610 |
|
377 |
359 |
$3K |
| 86618 |
|
837 |
805 |
$3K |
| 82043 |
|
2,231 |
2,186 |
$3K |
| 93225 |
|
124 |
99 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
12 |
12 |
$3K |
| 0064A |
|
235 |
199 |
$3K |
| 87186 |
|
1,785 |
1,667 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
110 |
106 |
$3K |
| 82950 |
|
751 |
718 |
$3K |
| 82746 |
|
661 |
638 |
$3K |
| 73502 |
|
258 |
239 |
$3K |
| 76642 |
|
65 |
62 |
$3K |
| 81025 |
|
4,604 |
4,351 |
$3K |
| 0124A |
|
230 |
226 |
$3K |
| 86702 |
|
1,162 |
1,074 |
$3K |
| 85652 |
|
3,500 |
3,290 |
$3K |
| 97802 |
|
52 |
52 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
282 |
273 |
$2K |
| 93971 |
|
53 |
49 |
$2K |
| 71250 |
|
52 |
49 |
$2K |
| 85610 |
|
3,666 |
2,657 |
$2K |
| 91322 |
|
36 |
36 |
$2K |
| 87205 |
|
2,201 |
2,065 |
$2K |
| 86701 |
|
1,165 |
1,074 |
$2K |
| 90656 |
|
165 |
165 |
$2K |
| 86765 |
|
1,111 |
1,038 |
$2K |
| 83880 |
|
850 |
762 |
$2K |
| 86787 |
|
1,044 |
973 |
$2K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
492 |
473 |
$2K |
| 81003 |
|
8,132 |
7,483 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
56 |
47 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
65 |
59 |
$2K |
| 99442 |
|
147 |
143 |
$2K |
| 80055 |
|
73 |
55 |
$2K |
| 83690 |
|
4,025 |
3,681 |
$2K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
1,050 |
310 |
$2K |
| 59025 |
Fetal non-stress test |
16 |
14 |
$1K |
| 76536 |
|
24 |
24 |
$1K |
| 72110 |
|
68 |
65 |
$1K |
| 93226 |
|
167 |
123 |
$1K |
| 82570 |
|
700 |
671 |
$1K |
| 80076 |
|
670 |
623 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,655 |
2,552 |
$1K |
| 94060 |
|
14 |
14 |
$1K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
200 |
147 |
$1K |
| 87469 |
|
187 |
181 |
$1K |
| 81001 |
|
3,868 |
3,453 |
$1K |
| 87340 |
|
1,186 |
1,125 |
$1K |
| 77080 |
|
37 |
37 |
$1K |
| 87468 |
|
175 |
169 |
$1K |
| 87484 |
|
175 |
169 |
$1K |
| 83970 |
|
93 |
91 |
$1K |
| 98926 |
|
275 |
258 |
$1K |
| 86762 |
|
876 |
828 |
$1K |
| 87070 |
|
1,407 |
1,377 |
$998.42 |
| 90480 |
|
153 |
153 |
$989.03 |
| 90670 |
|
98 |
92 |
$981.54 |
| 90662 |
|
415 |
396 |
$936.86 |
| 0004A |
|
82 |
81 |
$903.68 |
| 0013A |
|
61 |
59 |
$883.30 |
| 86038 |
|
222 |
214 |
$866.63 |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
12 |
12 |
$857.60 |
| 0054A |
|
48 |
47 |
$853.02 |
| 76942 |
|
120 |
108 |
$840.36 |
| 97803 |
|
25 |
25 |
$788.20 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
46 |
12 |
$785.71 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
31 |
31 |
$747.42 |
| 94664 |
|
185 |
141 |
$734.20 |
| 99460 |
|
12 |
12 |
$726.44 |
| 90732 |
|
18 |
15 |
$696.00 |
| 74018 |
|
41 |
39 |
$693.93 |
| 90734 |
|
122 |
104 |
$682.43 |
| 84403 |
|
41 |
38 |
$671.06 |
| 90674 |
|
39 |
39 |
$654.58 |
| 84600 |
|
62 |
57 |
$654.04 |
| 83520 |
|
215 |
188 |
$652.45 |
| 69209 |
|
60 |
59 |
$635.32 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
341 |
328 |
$550.70 |
| 97165 |
|
30 |
26 |
$537.44 |
| 91320 |
|
101 |
101 |
$524.40 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
883 |
832 |
$512.23 |
| 73562 |
|
65 |
51 |
$491.30 |
| 84550 |
|
554 |
505 |
$479.58 |
| 0001A |
|
72 |
69 |
$473.38 |
| 73110 |
|
85 |
76 |
$473.28 |
| 82947 |
|
183 |
169 |
$445.02 |
| 76770 |
|
13 |
12 |
$436.66 |
| 82962 |
|
3,062 |
1,618 |
$436.20 |
| 87478 |
|
99 |
94 |
$424.68 |
| 86235 |
|
71 |
56 |
$399.76 |
| 82565 |
|
423 |
401 |
$377.83 |
| 85730 |
|
400 |
351 |
$374.81 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
73 |
72 |
$335.12 |
| 84153 |
|
70 |
69 |
$329.83 |
| 86430 |
|
270 |
251 |
$308.03 |
| 84100 |
|
207 |
187 |
$295.93 |
| 93016 |
|
36 |
31 |
$264.23 |
| 82550 |
|
239 |
214 |
$247.94 |
| 86480 |
|
13 |
12 |
$247.92 |
| 0002A |
|
57 |
57 |
$240.90 |
| 72040 |
|
12 |
12 |
$223.45 |
| 97163 |
|
12 |
12 |
$221.74 |
| 96160 |
|
29 |
28 |
$215.42 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
33 |
15 |
$205.64 |
| 99401 |
|
16 |
13 |
$199.68 |
| 93018 |
|
37 |
31 |
$184.10 |
| 87150 |
|
15 |
13 |
$182.84 |
| 86481 |
|
31 |
28 |
$181.65 |
| 86901 |
|
1,495 |
1,363 |
$181.16 |
| 86850 |
|
1,282 |
1,183 |
$173.82 |
| 87400 |
|
152 |
145 |
$157.11 |
| 0031A |
|
12 |
12 |
$154.06 |
| 83605 |
|
1,173 |
1,016 |
$146.57 |
| 85379 |
|
518 |
469 |
$145.45 |
| 96367 |
|
12 |
12 |
$141.70 |
| 84484 |
|
3,924 |
3,214 |
$140.44 |
| 80305 |
|
1,072 |
969 |
$120.82 |
| 82105 |
|
13 |
13 |
$119.98 |
| 99024 |
|
14 |
12 |
$119.45 |
| 82150 |
|
80 |
77 |
$110.16 |
| 87040 |
|
388 |
320 |
$107.64 |
| 86200 |
|
98 |
90 |
$107.05 |
| 82784 |
|
12 |
12 |
$98.80 |
| 93270 |
|
29 |
12 |
$90.31 |
| 72125 |
Computed tomography, cervical spine; without contrast material |
12 |
12 |
$85.80 |
| 84481 |
|
13 |
13 |
$84.70 |
| G0432 |
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening |
13 |
12 |
$62.40 |
| 84163 |
|
13 |
12 |
$60.56 |
| G0009 |
Administration of pneumococcal vaccine |
25 |
24 |
$57.89 |
| 86706 |
|
14 |
14 |
$53.45 |
| 83516 |
|
14 |
12 |
$46.12 |
| 99441 |
|
17 |
16 |
$44.98 |
| 87210 |
|
63 |
59 |
$43.60 |
| 90715 |
|
2,260 |
2,118 |
$41.00 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
217 |
195 |
$38.80 |
| 90653 |
|
133 |
132 |
$38.00 |
| 87075 |
|
25 |
25 |
$37.88 |
| 82248 |
|
15 |
12 |
$30.12 |
| 83721 |
|
13 |
13 |
$28.11 |
| 82310 |
|
26 |
26 |
$26.75 |
| 82948 |
|
472 |
354 |
$19.55 |
| 86431 |
|
16 |
14 |
$17.01 |
| 82077 |
|
297 |
254 |
$15.23 |
| 84703 |
|
83 |
81 |
$15.04 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
397 |
378 |
$13.33 |
| 82044 |
|
55 |
53 |
$13.04 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,970 |
4,337 |
$5.96 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
15 |
15 |
$5.32 |
| 84520 |
|
12 |
12 |
$4.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
31 |
26 |
$3.53 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,288 |
3,719 |
$3.25 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,236 |
3,615 |
$3.04 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
439 |
370 |
$2.04 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
14 |
13 |
$1.65 |
| J7050 |
Infusion, normal saline solution, 250 cc |
956 |
735 |
$0.96 |
| 91301 |
|
844 |
624 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
750 |
664 |
$0.00 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
438 |
388 |
$0.00 |
| 95886 |
|
258 |
248 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,462 |
2,200 |
$0.00 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,635 |
1,487 |
$0.00 |
| J2704 |
Injection, propofol, 10 mg |
2,782 |
2,548 |
$0.00 |
| 96376 |
|
658 |
478 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
193 |
175 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
631 |
503 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
62 |
58 |
$0.00 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,976 |
1,753 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
110 |
105 |
$0.00 |
| G8952 |
Elevated or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given |
39 |
37 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
89 |
89 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
84 |
77 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
394 |
374 |
$0.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
582 |
466 |
$0.00 |
| A9270 |
Non-covered item or service |
866 |
692 |
$0.00 |
| Q2036 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) |
142 |
141 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
141 |
130 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
38 |
37 |
$0.00 |
| 90651 |
|
45 |
39 |
$0.00 |
| 84132 |
|
12 |
12 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
17 |
13 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
15 |
14 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
84 |
70 |
$0.00 |
| 94760 |
|
154 |
121 |
$0.00 |
| 91305 |
|
65 |
60 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
49 |
48 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
18 |
15 |
$0.00 |
| 90619 |
|
18 |
18 |
$0.00 |
| J2060 |
Injection, lorazepam, 2 mg |
49 |
40 |
$0.00 |
| 91306 |
|
42 |
30 |
$0.00 |
| G8980 |
Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting |
13 |
12 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
460 |
427 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,031 |
1,728 |
$0.00 |
| 91300 |
|
342 |
186 |
$0.00 |
| 81401 |
|
43 |
37 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14 |
12 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
1,112 |
849 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,073 |
946 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
94 |
80 |
$0.00 |
| 91312 |
|
120 |
117 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
29 |
25 |
$0.00 |
| G0071 |
Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only |
29 |
24 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
209 |
185 |
$0.00 |
| J1956 |
Injection, levofloxacin, 250 mg |
26 |
24 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
54 |
40 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
55 |
50 |
$0.00 |
| 94729 |
|
14 |
14 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
13 |
12 |
$0.00 |
| 94727 |
|
14 |
14 |
$0.00 |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
16 |
16 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
26 |
25 |
$0.00 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
24 |
15 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
16 |
16 |
$0.00 |
| 90633 |
|
14 |
14 |
$0.00 |